Filtros de búsqueda

Lista de obras de

A health economic guide to market access of biosimilars

artículo científico publicado en 2020

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

artículo científico publicado en 2017

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

artículo científico publicado en 2020

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure

scientific article published on 30 March 2020

Biosimilars in Belgium: a proposal for a more competitive market

scientific article published on 13 May 2020

Comparative evaluation of three chromogenic agars for detection and rapid identification of aerobic Gram-negative bacteria in the normal intestinal microflora ⬇️

artículo científico publicado el 1 de septiembre de 2003

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.

artículo científico publicado en 2019

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2-Biosimilar and Originator Etanercept in the Outpatient Setting.

artículo científico publicado en 2019

Economic evaluation of biosimilars for reimbursement purposes - what, when, how?

scientific article published on 15 March 2020

European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption

artículo científico publicado en 2020

European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice

artículo científico publicado en 2020

Guidelines for the practical stability studies of anticancer drugs: A European consensus conference ⬇️

artículo científico publicado el 3 de agosto de 2011

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

artículo científico publicado en 2020

In vitro susceptibility to antimicrobial drugs of 62 Salmonella strains isolated from horses in The Netherlands ⬇️

artículo científico publicado el 1 de junio de 1995

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

artículo científico publicado en 2020

NosocomialMycobacteriumbovis–Bacille Calmette‐Guérin Infections Due to Contamination of Chemotherapeutics: Case Finding and Route of Transmission ⬇️

artículo científico publicado el 15 de octubre de 2003

Policies for biosimilar uptake in Europe: An overview.

artículo científico publicado en 2017

Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review

artículo científico publicado en 2020

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

artículo científico publicado en 2017

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

scientific article published on 01 July 2019

The impact of reference-pricing systems in Europe: a literature review and case studies ⬇️

artículo científico publicado el 1 de diciembre de 2011

glycyrrhizin as a potential treatment for chronic hepatitis C ⬇️

artículo científico publicado el 1 de marzo de 1998

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda